CARsgen Therapeutics Holdings Limited

HKEX:2171.HK

4.79 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019
Operating Activities:
Net Income -747.387-890.952-4,736.778-1,064.049-265.133
Depreciation & Amortization 87.39581.53352.44640.10919.569
Deferred Income Tax 51.42904,151.772703.42739.704
Stock Based Compensation 14.45843.99513.5041.7141.927
Change In Working Capital 211.37543.48213.37913.45127.284
Accounts Receivables 0.003-0.003-0.0070-0.002
Inventory -0.6830000
Accounts Payables 00000
Other Working Capital 212.05843.48513.38613.45127.286
Other Non Cash Items -72.20578.894-6.64510.198-2.355
Operating Cash Flow -454.935-643.048-512.322-295.15-179.004
Investing Activities:
Investments In Property Plant And Equipment -9.549-138.614-178.453-18.735-103.459
Acquisitions Net 47.15102,315.65400
Purchases Of Investments -2,037.989-3,482.681-4,758.82200
Sales Maturities Of Investments 2,037.9895,925.6832,443.1680170.142
Other Investing Activites 1.64982.602-2,292.86811.83816.302
Investing Cash Flow 39.2512,386.99-2,471.321-6.89782.985
Financing Activities:
Debt Repayment -4.851-327.748-146.865-157.777-244.121
Common Stock Issued 6.6110.5052,576.08200
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities -0.30380.729244.8151,460.25271.648
Financing Cash Flow -22.142-236.5142,674.0321,302.47327.527
Other Information:
Effect Of Forex Changes On Cash 19.54269.324-42.074-53.9331.415
Net Change In Cash -418.2841,576.752-351.685946.493-67.077
Cash At End Of Period 1,849.7522,268.036691.2841,042.96996.476